PAYO vs. HQY, MEDP, BILI, WPP, LYFT, AMTM, MARA, SEZL, ETSY, and WSC
Should you be buying Payoneer Global stock or one of its competitors? The main competitors of Payoneer Global include HealthEquity (HQY), Medpace (MEDP), Bilibili (BILI), WPP (WPP), Lyft (LYFT), Amentum (AMTM), Marathon Digital (MARA), Sezzle (SEZL), Etsy (ETSY), and WillScot (WSC). These companies are all part of the "business services" industry.
Payoneer Global vs. Its Competitors
HealthEquity (NASDAQ:HQY) and Payoneer Global (NASDAQ:PAYO) are both mid-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.
HealthEquity has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Comparatively, Payoneer Global has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500.
HealthEquity currently has a consensus price target of $118.09, suggesting a potential upside of 16.60%. Payoneer Global has a consensus price target of $10.44, suggesting a potential upside of 50.61%. Given Payoneer Global's higher probable upside, analysts clearly believe Payoneer Global is more favorable than HealthEquity.
In the previous week, HealthEquity had 13 more articles in the media than Payoneer Global. MarketBeat recorded 16 mentions for HealthEquity and 3 mentions for Payoneer Global. HealthEquity's average media sentiment score of 0.98 beat Payoneer Global's score of 0.37 indicating that HealthEquity is being referred to more favorably in the media.
Payoneer Global has lower revenue, but higher earnings than HealthEquity. Payoneer Global is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.
Payoneer Global has a net margin of 11.32% compared to HealthEquity's net margin of 9.80%. Payoneer Global's return on equity of 15.70% beat HealthEquity's return on equity.
99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 82.2% of Payoneer Global shares are owned by institutional investors. 1.5% of HealthEquity shares are owned by company insiders. Comparatively, 2.6% of Payoneer Global shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
HealthEquity beats Payoneer Global on 9 of the 15 factors compared between the two stocks.
Get Payoneer Global News Delivered to You Automatically
Sign up to receive the latest news and ratings for PAYO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PAYO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Payoneer Global Competitors List
Related Companies and Tools
This page (NASDAQ:PAYO) was last updated on 7/3/2025 by MarketBeat.com Staff
